Provasctec
1 known investors
Find your way into Provasctec
152 people in our graph share verified history with the Provasctec team — schools, employers, funds. One of them is your warm intro.
Joe Maseunlockedknows Holger Muller · together at Athenex (overlapped)
knows the team · via Liom
×2knows the team · via Biognosys AG
×2knows the team · via Cytel
×3knows the team · via Health Advances
×3knows the team · via University College Cork
Provasctec develops a cell therapy combining mesenchymal stem cells with a biodegradable delivery device to create new vascular pathways, with a lead program targeting critical limb ischemia in peripheral artery disease patients. The company operates in regenerative medicine, applying biomaterial engineering and precision cell delivery to conditions including inflammation, cancer, and age-related diseases.
Founders & leadership
HM
Holger MullerCEO & Co-FounderHolger Muller is CEO and co-founder of Provasctec, a regenerative medicine company developing a cell therapy that combines mesenchymal stem cells with a biodegradable delivery device to form new vascular pathways, with a lead program addressing critical limb ischemia. He has held C-level roles at innovation-focused companies and has a scientific background combined with financial experience.
NC
Noel CapliceCSO & Co-FounderNoel Caplice is a cardiologist and vascular biologist with over 30 years of clinical and research experience, including a PhD in vascular biology from Australia and interventional cardiology fellowship training at Mayo Clinic; he has held senior academic positions at University College Cork and Mayo Clinic, authored over 200 scientific publications, and holds more than 15 US/EU patents in vascular and cell therapy applications. He co-founded Provasctec, a cell therapy company targeting vascular disease, where he serves as Chief Scientific Officer.
Investors · 1
NLClisted by NLCAmsterdam
How we know: NLC's portfolio page · Not right? Tell us
Frequently asked questions
- What does Provasctec do?
- Provasctec develops a cell therapy combining mesenchymal stem cells with a biodegradable delivery device to create new vascular pathways, with a lead program targeting critical limb ischemia in peripheral artery disease patients. The company operates in regenerative medicine, applying biomaterial engineering and precision cell delivery to conditions including inflammation, cancer, and age-related diseases.
- Who founded Provasctec?
- Provasctec was founded by Holger Muller, Noel Caplice.
- Who are Provasctec's investors?
- Provasctec's investors include NLC.